Brain protein serine/threonine phosphatases

Current Opinion in Neurobiology

Volumn 9, Issue 3, 1999, Pages 336-342

  Price, Nancy E ^a   Mumby, Marc C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ENZYME; CALCINEURIN; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN SERINE THREONINE KINASE;

BRAIN; ENZYME ACTIVITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 0033153258     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(99)80049-X     Document Type: Article

References (68)

1. Cohen PTW: Novel protein serine/threonine phosphatases: Variety is the spice of life. Trends Biochem Sci 1997, 22:245-251.
2. Bray D: Signaling complexes: Biophysical constraints on intracellular communication. Annu Rev Biophys Biomol Struct 1998, 27:59-75.
3. Pawson T, Scott JD: Signaling through scaffold, anchoring, and adaptor proteins. Science 1997, 278:2075-2080.
4. Kornau HC, Seeburg PH, Kennedy MB: Interaction of ion channels and receptors with PDZ domain proteins. Curr Opin Neurobiol 1997, 7:368-373.
5. da Cruz e Silva EF, Fox CA, Ouimet CC, Gustafson E, Watson SJ, Greengard P: Differential expression of protein phosphatase 1 isoforms in mammalian brain. J Neurosci 1995, 15:3375-3389.
6. Ouimet CC, da Cruz e Silva EF, Greengard P: The alpha and gamma 1 isoforms of protein phosphatase 1 are highly and specifically concentrated in dendritic spines. Proc Natl Acad Sci USA 1995, 92:3396-3400.
7. 2+/calmodulin-dependent protein kinase II by protein phosphatases 1 and 2A. J Neurochem 1997, 68:2119-2128.
8. Allen PB, Ouimet CC, Greengard P: Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. Proc Natl Acad Sci USA 1997, 94:9956-9961. Describes the identification and cloning of a neuron-specific targeting protein for PP1. These observations provide evidence that PP1 is adapted to carry out specific roles in neurons through association with unique targeting subunits.
9. Satoh A, Nakanishi H, Obaishi H, Wada M, Takahashi K, Satoh K, Hirao K, Nishioka H, Hata Y, Mizoguchi A, Takai Y: Neurabin-II/ spinophilin. An actin filament-binding protein with one PDZ domain localized at cadherin-based cell-cell adhesion sites. J Biol Chem 1998, 273:3470-3475.
10. Colbran RJ, Bass MA, McNeill RB, Bollen M, Zhao S, Wadzinski BE, Strack S: Association of brain protein phosphatase 1 with cytoskeletal targeting/regulatory subunits. J Neurochem 1997, 69:920-929.
11. Sim ATR, Ratcliffe E, Mumby MC, Villa-Moruzzi E, Rostas JAP: Differential activities of protein phosphatase types 1 and 2A in cytosolic and participate fractions from rat forebrain. J Neurochem 1994, 62:1552-1559.
12. Shields SM, Ingebritsen TS, Kelly PT: Identification of protein phosphatase 1 in synaptic junctions: Dephosphorylation of endogenous calmodulin-dependent kinase II and synapse-enriched phosphoproteins. J Neurosci 1985, 5:3414-3422.
13. Strack S, Westphal RS, Colbran RJ, Ebner FF, Wadzinski BE: Protein serine/threonine phosphatase 1 and 2A associate with and dephosphorylate neurofilaments. Brain Res Mol Brain Res 1997, 49:15-28.
14. Liao H, Li YR, Brautigan DL, Gundersen GG: Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein tau. J Biol Chem 1998, 273:21 901-21908.
15. Kennedy MB: Signal transduction molecules at the glutamatergic postsynaptic membrane. Brain Res Brain Res Rev 1998, 26:243-257.
16. Braun AP, Schulman H: The multifunctional calcium/calmodulin-dependent protein kinase: From form to function. Annu Rev Physiol 1995, 57:417-445.
17. Greengard P, Nairn AC, Girault JA, Ouimet CC, Snyder GL, Fisone G, Allen PB, Fienberg A, Nishi A: The DARPP-32 protein phosphatase 1 cascade - A model for signal integration. Brain Res Rev 1998, 26:274-284.
18. Fienberg AA, Hiroi N, Mermelstein PG, Song WJ, Snyder GL, Nishi A, Cheramy A, Ocallaghan JP, Miller DB, Cole DG et al.: DARPP-32 -regulator of the efficacy of dopaminergic neurotransmission. Science 1998, 281:838-842. Deletion of the gene for DARPP-32 in mice causes a dramatic loss in the response of neostriatal neurons to dopamine. The authors demonstrate that the DARPP-32/PP1 cascade is an obligatory component, along with PKA, in dopamine signaling. This is one of two published studies (see also [19•]) demonstrating a specific physiological function that can be attributed to PP1 in intact animals.
19. Yan Z, Hsieh-Wilson L, Feng JA, Tomizawa K, Allen PB, Fienberg AA, Nairn AC, Greengard P: Protein phosphatase 1 modulation of neostriatal AMPA channels: Regulation by DARPP-32 and spinophilin. Nat Neurosci 1999, 2:13-17. This paper shows that disruption of spinophilin targeting of PP1 can disrupt regulation of AMPA channels. The authors report that loss of targeting of a PSP leads to loss of function in intact cells.
20. Wang X, Robinson PJ: Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J Neurochem 1997, 68:443-456.
21. Hall KU, Collins SP, Gamm DM, Massa E, DePaoli-Roach AA, Uhler MD: Phosphorylation-dependent inhibition of protein phosphatase-1 by G-substrate - A purkinje cell substrate of the cyclic GMP-dependent protein kinase. J Biol Chem 1999, 274:3485-3495.
22. Endo S, Suzuki M, Sumi M, Nairn AC, Morita R, Yamakawa K, Greengard P, Ito M: Molecular identification of human G-substrate, a possible downstream component of the cGMP-dependent protein kinase cascade in cerebellar purkinje cells. Proc Natl Acad Sci USA 1999, 96:2467-2472.
23. Wera S, Hemmings BA: Serine/threonine protein phosphatases. Biochem J 1995, 311:17-29.
24. Mayer RE, Hendrix P, Cron P, Matthies R, Stone SR, Goris J, Merlevede W, Hofsteenge J, Hemmings BA: Structure of the 55 kDA regulatory subunit of protein phosphatase 2A: Evidence for a neuronal-specific isoform. Biochemistry 1991, 30:3589-3597.
25. Zolnierowicz S, Csortos C, Bondor J, Verin A, Mumby MC, DePaoli-Roach AA: Diversity in the regulatory B-subunits of protein phosphatase 2A: Identification of a novel isoform highly expressed in brain. Biochemistry 1994, 33:11858-11867.
26. McCright B, Virshup DM: Identification of a new family of protein phosphatase 2A regulatory subunits. J Biol Chem 1995, 270:26123-26128.
27. Csortos C, Zolnierowicz S, Bako E, Durbin SD, DePaoli-Roach AA: High complexity in the expression of the b′ subunit of protein phosphatase 2A0. Evidence for the existence of at least seven novel isoforms. J Biol Chem 1996, 271:2578-2588.
28. Strack S, Zaucha JA, Ebner FF, Colbran RJ, Wadzinski BE: Brain protein phosphatase 2A: Developmental regulation and distinct cellular and subcellular localization by B subunits. J Comp Neurol 1998, 392:515-527.
29. Chen TC, Law B, Kondratyuk T, Rossie S: Identification of soluble protein phosphatases that dephosphorylate voltage-sensitive sodium channels in rat brain. J Biol Chem 1995, 270:7750-7756.
30. 2+/calmodulin-dependent protein kinase II by protein phosphatases 1 and 2A. J Neurochem 1997, 68:2119-2128.
31. Barnes GN, Slevin JT, Vanaman TC: Rat brain protein phosphatase 2A: An enzyme that may regulate autophosphorylated protein kinases. J Neurochem 1995, 64:340-353.
32. 2+-calmodulin-dependent protein kinase IV and protein phosphatase 2A. Science 1998, 280:1258-1261. The authors describe a physical association between PP2A and a protein kinase. Previous studies using inhibitors of PSPs implicated PP2A in the regulation of a number of protein kinases. The data reported here support those findings and describe a mechanisms through which PP2A could act as a ubiquitous regulator of kinases. Similar complexes of PP2A and neuronal protein kinases are likely to exist.
33. Westphal RS, Coffee RL, Marotta A, Pelech SL, Wadzinski BE: Identification of kinase-phosphatase signaling modules composed of p70 S6 kinase-protein phosphatase 2A (PP2A) and p21 -activated kinase-PP2a. J Biol Chem 1999, 274:687-692.
34. Saito T, Shima H, Osawa Y, Nagao M, Hemmings BA, Kishimoto T, Hisanaga S: Neurofilament-associated protein phosphatase 2A: Its possible role in preserving neurofilaments in filamentous states. Biochemistry 1995, 34:7376-7384.
35. Strack S, Westphal RS, Colbran RJ, Ebner FF, Wadzinski BE: Protein serine/threonine phosphatase 1 and 2A associate with and dephosphorylate neurofilaments. Brain Res Mol Brain Res 1997, 49:15-28.
36. Lee VM: Disruption of the cytoskeleton in Alzheimer's disease. Curr Opin Neurobiol 1995, 5:663-668.
37. Mandelkow EM, Schweers O, Drewes G, Biernat J, Gustke N, Trinczek B, Mandelkow E: Structure, microtubule interactions, and phosphorylation of tau protein. Ann NY Acad Sci 1996, 777:96-106.
38. Billingsley ML, Kincaid RL: Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J 1997, 323:577-591.
39. Sontag E, Nunbhakdi-Craig V, Bloom GS, Mumby MC: A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J Cell Biol 1995, 128:1131 -1144.
40. Merrick SE, Demoise DC, Lee VMY: Site-specific dephosphorylation of tau protein at Ser202/Thr205 in response to microtubule depolymerization in cultured human neurons involves protein phosphatase 2A. J Biol Chem 1996, 271:5589-5594.
41. Sontag E, Nunbhakdi-Craig V, Lee G, Bloom GS, Mumby MC: Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A. Neuron 1996, 17:1201-1207.
42. Merrick SE, Trojanowski JQ, Lee VMY: Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons (NT2N cells). J Neurosci 1997, 17:5726-5737. This paper shows that induction of tau hyperphosphorylation with okadaic acid correlates with the loss of stable microtubules and degeneration of axons in cultured neuronal cells. The results demonstrate that PSPs play a constitutive role in dephosphorylation of tau. Suppression of phosphatase activity leads to phosphorylation and functional changes similar to those in pathological states, such as in Alzheimer's disease.
43. Klee CB, Ren H, Wang X: Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 1998, 273:13367-13370.
44. Strack S, Wadzinski BE, Ebner FF: Localization of the calcium/calmodulin-dependent protein phosphatase, calcineurin, in the hindbrain and spinal cord of the rat. J Comp Neural 1996, 375:66-76.
45. Kuno T, Mukai H, Ito A, Chang CD, Kishima K, Saito N, Tanaka C: Distinct cellular expression of calcineurin A alpha and A beta in rat brain. J Neurochem 1992, 58:1643-1651.
46. Halpain S, Hipolito A, Saffer L: Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. J Neurosci 1998, 18 :9835-9844.
47. Dawson TM, Steiner JP, Lyons WE, Fotuhi M, Blue M, Snyder SH: The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: Relationship to calcineurin. Neuroscience 1994, 62:569-580.
48. Snyder SH, Lai MM, Burnett PE: Immunophilins in the nervous system. Neuron 1998, 21:283-294.
49. Coghlan VM, Perrino BA, Howard M, Langeberg LK, Hicks B, Gallatin WM, Scott JD: Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 1995, 267:108-111.
50. Lai MM, Burnett PE, Wolosker H, Blackshaw S, Snyder SH: Cain, a novel physiologic protein inhibitor of calcineurin. J Biol Chem 1998, 273:18325-18331.
51. Yakel JL: Calcineurin regulation of synaptic function: From ion channels to transmitter release and gene transcription. Trends Pharmacol Sci 1997, 18:124-134.
52. Winder DG, Mansuy IM, Osman M, Moallem TM, Kandel ER: Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin. Cell 1998, 92:25-37. This paper shows that expression of activated calcineurin in the brains of transgenic mice leads to alterations in a novel phase of long-term potentiation. These alterations took place in the CA1 region of the hippocampus where calcineurin is expressed at high levels. The observations provide evidence for a physiological function for calcineurin in intact animals.
53. Mansuy IM, Mayford M, Jacob B, Kandel ER, Bach ME: Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell 1998, 92:39-49. This paper shows that regulated expression of activated calcineurin causes alterations in long-term memory. Constitutively active calcineurin caused a loss of long-term memory that could be reversed when calcineurin expression was terminated. These observations provide an elegant demonstration of the role of calcineurin in memory.
54. Kayyali US, Zhang W, Yee AG, Seidman JG, Potter H: Cytoskeletal changes in the brains of mice lacking calcineurin A alpha. J Neurochem 1997, 68:1668-1678.
55. Takekawa M, Maeda T, Saito H: Protein phosphatase 2C-alpha inhibits the human stress-responsive p38 and JNK MAPK pathways. EMBO J 1998, 17:4744-4752.
56. 2+/calmodulin- Dependent protein kinase II by protein phosphatase 2C. J Biol Chem 1993, 268:133-137.
57. Desdouits F, Siciliano JC, Nairn AC, Greengard P, Girault JA: Dephosphorylation of Ser-137 in DARPP-32 by protein phosphatases 2A and 2C: Different roles in vitro and in striatonigral neurons. Biochem J 1998, 330:211-216.
58. GI) subunit of the glycogen-associated protein phosphatase. J Biol Chem 1991, 266:15782-15789.
59. Doherty MJ, Moorhead G, Morrice N, Cohen P, Cohen PT: Amino acid sequence and expression of the hepatic glycogen-binding (GL)-subunit of protein phosphatase-1. FEBS Lett 1995, 375:294-298.
60. Printen JA, Brady MJ, Saltiel AR: PTG, a protein phosphatase 1 -binding protein with a role in glycogen metabolism. Science 1997, 275:1475-1478.
61. Chen YH, Chen MX, Alessi DR, Campbell DG, Shanahan C, Cohen P, Cohen PT: Molecular cloning of cDNA encoding the 110 kDa and 21 kDa regulatory subunits of smooth muscle protein phosphatase 1M. FEBS Lett 1994, 356:51-55.
62. Shimizu H, Ito M, Miyahara M, Ichikawa K, Okubo S, Konishi T, Naka M, Tanaka T, Hirano K, Hartshorne DJ: Characterization of the myosin-binding subunit of smooth muscle myosin phosphatase. J Biol Chem 1994, 269:30407-30411.
63. Helps NR, Barker HM, Elledge SJ, Cohen PT: Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53. FEBS Lett 1995, 377:295-300.
64. Van EA, Wera S, Beullens M, Torrekens S, Van LF, Stalmans W, Bollen M: Molecular cloning of NIPP-1, a nuclear inhibitor of protein phosphatase-1, reveals homology with polypeptides involved in RNA processing. J Biol Chem 1995, 270:28068-28074.
65. Allen PB, Kwon YG, Nairn AC, Greengard P: Isolation and characterization of PNUTS, a putative protein phosphatase 1 nuclear targeting subunit. J Biol Chem 1998, 273:4089-4095.
66. Hendrix P, Mayer-Jaekel RE, Cron P, Goris J, Hofsteenge J, Merlevede W, Hemmings BA: Structure and expression of a 72 kDa regulatory subunit of protein phosphatase 2A. Evidence for different size forms produced by alternative splicing. J Biol Chem 1993, 268:15267-15276.
67. Voorhoeve PM, Hijmans EM, Bernards R: Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein. Oncogene 1999, 18:515-524.
68. Egloff MP, Johnson DF, Moorhead G, Cohen PT, Cohen P, Barford D: Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1. EMBO J 1997, 16:1876-1887.